Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer
Authors:
- Maria RadanovaMRMaria Radanova
- Galya MihaylovaGMGalya Mihaylova
- Zhasmina MihaylovaZMZhasmina Mihaylova
- Desislava IvanovaDIDesislava Ivanova
- Oskan TasinovOskan Tasinov
- Neshe Nazifova-TasinovaNNNeshe Nazifova-Tasinova
- Pavel PavlovPPPavel Pavlov
- Milko MirchevMMMilko Mirchev
- Nikolay ConevNCNikolay Conev
- Ivan DonevIDIvan Donev
Open Access
- 15 March 2021
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 28 (2) , 1204-1215
Abstract
The present study evaluated the prognostic role of circulating miRNA-618 in patients with metastatic colon cancer (mCC) and whether miR-618 gene rs2682818 single nucleotide polymorphisms (SNP) are associated with colon cancer susceptibility and expression levels of mature miR-618. In total, 104 patients with mCC before starting the chemotherapy were investigated. The expression status of circulating miR-618 in mCC was evaluated by quantitative PCR. TaqMan PCR assay was used for rs2682818 SNP genotyping. miR-618 was overexpressed in serum of mCC patients. Patients with high and intermediate expression of miR-618 had a significantly longer mean overall survival (OS) of 21 months than patients with low expression—16 months. In addition, multivariate Cox regression analysis confirmed the association between high/intermediate levels of miRNA-618 and longer OS, HR = 0.51, 95% CI: 0.30–0.86, p = 0.012. miR-618 rs2682818 SNP significantly decreased the risk of colon cancer susceptibility in both heterozygous codominant (AC vs. CC, OR = 0.39, 95% CI: 0.17–0.88, p = 0.024) and overdominant (AC vs. CC + AA, OR = 0.37, 95% CI: 0.16–0.85, p = 0.018) genetic models. Our data suggest that circulating miRNA-618 could be useful as a prognostic biomarker in mCC. Patients harboring AC rs2682818 genotype have a decreased risk for colon cancer in comparison with patients with CC and AA genotypes.Keywords
Funding Information
- Bulgarian National Science Fund (КП-06-Н23/6, 18.12.2018)
- Medical University of Varna, Bulgaria (FMS-53/18.12.2017)
This publication has 40 references indexed in Scilit:
- Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resectionTranslational Research, 2013
- Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancerOncology Reports, 2013
- Differential Expression of miR-145 in Children with Kawasaki DiseasePLOS ONE, 2013
- MicroRNA Expression Signatures during Malignant Progression from Barrett's Esophagus to Esophageal AdenocarcinomaCancer Prevention Research, 2013
- The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal CancerPLOS ONE, 2012
- PI3K expression and PIK3CA mutations are related to colorectal cancer metastasesWorld Journal of Gastroenterology, 2012
- Single-nucleotide polymorphisms among microRNA: big effects on cancerChinese Journal of Cancer, 2011
- TGF-β signaling alterations and susceptibility to colorectal cancerHuman Molecular Genetics, 2007
- Duel nature of TGF-?? signaling: tumor suppressor vs. tumor promoterCurrent Opinion in Oncology, 2005
- Measuring the Accuracy of Diagnostic SystemsScience, 1988